Comparison of tacrolimus with neoral as primary immunosuppression in hepatitis C patients after liver transplantation

Transplant Proc. 1998 Jun;30(4):1405-6. doi: 10.1016/s0041-1345(98)00291-7.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial

MeSH terms

  • Adult
  • Aged
  • Cyclosporine / adverse effects
  • Cyclosporine / therapeutic use*
  • Female
  • Graft Rejection / epidemiology
  • Hepacivirus / isolation & purification
  • Hepatitis C / physiopathology
  • Hepatitis C / surgery*
  • Hepatitis C / virology
  • Humans
  • Immunosuppressive Agents / adverse effects
  • Immunosuppressive Agents / therapeutic use*
  • Incidence
  • Liver Neoplasms / immunology*
  • Male
  • Methylprednisolone / therapeutic use
  • Middle Aged
  • RNA, Viral / analysis
  • Recurrence
  • Tacrolimus / adverse effects
  • Tacrolimus / therapeutic use*

Substances

  • Immunosuppressive Agents
  • RNA, Viral
  • Cyclosporine
  • Tacrolimus
  • Methylprednisolone